Drugs / Fluticasone/Azelastine
last change Feb 2020 re-read 9 days ago

Fluticasone/Azelastine

Developed for
allergic rhinitis
Investigated by
University of Chicago

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02402465 Feb 2015 → Mar 2018 allergic rhinitis University of Chicago Completed Missed primary

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Fluticasone/Azelastine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02402465 ↗